CathepsinS is a potential target of autoimmune disease. A series of proline derived compounds were synthesized and evaluated as cathepsinSinhibitors. We discovered potentcathepsinSinhibitors through structure–activity relationship studies of proline analogues. In particular, compound 19-(S) showed promising in vitro/vivo pharmacological activities and properties as a selective cathepsinS inhibitor